Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | RARG | P13631 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5763337 | 0.99 | ALDH1A1 (0.39) | NPC1ALDH1A1RAB9AHPGDHDAC1 | |
| SCHEMBL1749274 | 0.79 | PPARA (0.43) | NPC1ALDH1A1RAB9A | |
| SCHEMBL1750513 | 0.79 | NPC1 (0.40) | NPC1ALDH1A1RAB9AHDAC1HDAC6 | |
| SCHEMBL1750514 | 0.79 | NPC1 (0.40) | NPC1ALDH1A1RAB9AHDAC1HDAC6 | |
| SCHEMBL1749272 | 0.79 | PPARA (0.43) | NPC1ALDH1A1RAB9A | |
| SCHEMBL5762678 | 0.79 | HPGD (0.39) | NPC1ALDH1A1RAB9AHPGDADRB2 | |
| SCHEMBL5762545 | 0.79 | HPGD (0.38) | NPC1ALDH1A1RAB9AHPGDADRB2 | |
| SCHEMBL1750539 | 0.79 | NPC1 (0.39) | NPC1ALDH1A1RAB9AHDAC1HDAC6 | |
| SCHEMBL1750205 | 0.79 | PPARA (0.42) | NPC1ALDH1A1RAB9A | |
| SCHEMBL1750204 | 0.79 | PPARA (0.42) | NPC1ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638964-A1 | NOVEL COMPOUNDS THAT MODULATE PPAR-GAMMA TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | Galderma Research & Development, S.N.C. (FR) | 2006-03-29 | — | — | EP | disclosed |
| WO-2004113331-A1 | NOVEL COMPOUNDS THAT MODULATE PPARϜ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2004-12-29 | — | — | WO | disclosed |